レボドロプロピジン: 周回性抗咳剤の総合的なレビュー
Sandeep Nayar1, Agam Vora2, Mangesh Tiwaskar3
1Principal Director and Head of Department, Department of Respiratory Medicine, Allergy & Sleep Disorders, BLK-Max Super Speciality Hospital, New Delhi, India.
The Journal of the Association of Physicians of India
|August 21, 2025
まとめ
周辺咳抑制剤であるレボドロプロピジンは,非生産性のある咳の症状を効果的に軽減します. 中心抗咳剤に匹敵する効能だが,安全性も優れ,副作用も少ない.
科学分野:
- 薬理学について
- 臨床医学
- 呼吸器医学
背景:
- 咳はインドのプライマリーケアでよく見られる症状で,患者の生活の質に大きく影響します.
- 咳の症状緩和は,病因学的治療と共にしばしば必要である.
- 非生産的な咳の管理は,抗咳剤から利益を得ます.
研究 の 目的:
- レボドロピジン の薬理学的側面をレビューする.
- レボドロプロピジン の有効性と安全性を支持する臨床的証拠を要約します.
- 咳の管理におけるレボドロピジンの治療的役割を定義する.
主な方法:
- 薬物の側面に関する包括的な文献レビュー
- 臨床試験の有効性と安全性に関するデータの分析
- レボドロピジンの使用の評価
主要な成果:
- レボドロプロピジンは,咳の重度と頻度を減らすために,中央抗咳剤に匹敵する有効性を示しています.
- レボドロプロピジンは,中枢神経系 (CNS) の副作用を最小限に抑える優れた安全性プロファイルを示しています.
- 広範な研究は,様々な患者集団と状態でその使用を支持しています.
結論:
- レボドロプロピジン (Levodropropizine) は,症状のある咳の治療に有効な非オピオイドの周辺性咳止め剤である.
- その好ましい安全性プロファイルは,従来の中央抗咳剤と比較して賢明な選択です.
- このレビューは,レボドロピジンが咳の治療における確立された場所の証拠を固める.
関連する概念動画
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
430
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
430
Drugs Used in Upper Respiratory Disorders: Overview
358
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
358
Drugs Used in Lower Respiratory Disorders: Overview
578
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
578
Upper Respiratory Drugs: Decongestants
374
Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
Most decongestants are readily available over-the-counter in...
374
Upper Respiratory Drugs: First and Second-Generation Antihistamines
456
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
456
Antiasthma Drugs: Leukotriene Modifiers
463
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
463


